Chengdu Microchip Pharmaceutical Co., Ltd., established on 2014-04-28, Business scope includes licensed projects:pharmaceutical production[Branch operation];Drug Wholesale;Drug retail(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Non-residential real estate leases;property management;car park service(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).

Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of small molecule drugs. Its products include original medicine such as Chidamide, Chiglitazar, Chiauranib. It also engages in technological licensing. The company was founded by Xian Ping Lu and Zhi Qiang Ning on March 21, 2001 and is headquartered in Shenzhen, China.

ALZA Corp. is a pharmaceutical and medical systems company that develops, manufactures, and markets therapeutic systems. It provides oral, transdermal, implantable, and liposomal technologies. It is also focused on drug delivery systems with over 20 prescription pharmaceutical products. With over 10,000 employees, ALZA Corp. is a subsidiary of Johnson & Johnson. It was established in 1968 by Dr Alejandro Zaffaroni. It is based inVacaville, California.

Novomics develops cancer treatment-linked diagnosis systems based on its expertise and knowledge in the field of molecular diagnosis. A significant strength of Novomics is its network of specialists and clinicians, as well as the knowledge gains made possible by technological advancements in the age of precision medicine. By embracing cutting-edge clinical, molecular biological, and academic achievements and forming close collaborative relationships with pharmaceutical companies and hospitals that are significant players in the medical industry.

Celgene Corporation is an American biotechnology company that discovers, develops and commercializes medicines for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. The company's major product is Revlimid (lenalidomide), in combination with dexamethasone for the treatment of multiple myeloma patients. Revlimid is also approved in the United States for the treatment of patients with transfusion-dependent anemia, due to Low- or Intermediate-1-risk Myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities. Revlimid is sold through proprietary risk-management distribution programs, to ensure safe and appropriate use of these pharmaceuticals. Vidaza is approved for the treatment of patients with MDS.

Apotex is a Canadian owned pharmaceutical company, and the largest producer of generic medicines in the country. Founded in 1974, the company has focused on research, development, manufacturing and distribution. Apotex has steadily grown to employ over 10,000 people around the world. Apotex Pharmachem is a global, fully integrated API R&D and manufacturing organization with its headquarters located in Brantford, Ontario, and is a member of the Apotex group of companies. Apotex Pharmachem has multiple facilities around the world located in Canada, India, Mexico, and China. Learn more at www.ApotexPharmachem.com.

CrownBio is a Cutting Edge Translational Technology Company Making Precision Medicine a Reality CrownBio brings clarity to drug discovery around the world by helping biopharmaceutical companies solve some of today's most pressing challenges in oncology, cardiovascular, and metabolic disease Drug Discovery. Their premier Translational Platforms for cancer and metabolic disease help our clients accelerate their new drug development programs. CrownBio develops world-leading preclinical efficacy models and provides both in vitro and in vivo testing services and preclinical research products. They are a global company with facilities across the world in the United States, United Kingdom, China, and Taiwan.

BioNumerik Pharmaceuticals, Inc. discovers and develops new medicines for cancer treatment. The firm's products include Tavocept which has the potential to substantially increase patient survival in the most common type of lung cancer and possibly many other forms of cancer, and Karenitecin which is an investigational new anti-tumor drug in the camptothecin class of chemotherapy drugs. The company was founded by Frederick H. Hausheer on December 15, 1992 and is headquartered in San Antonio, TX.

Seoul National University Hospital (서울대학교병원) is one of the oldest and biggest hospitals in South Korea. It is a general and teaching hospital of Seoul National University's College of Medicine. Except SNUH Healthcare System Gangnam Center, all branches have an emergency department (ED).

Kookmin University Industry-Academic Cooperation is an independent academic corporation.

Yantai Shuangta Food Co., Ltd., established on 1992-09-10, Business scope includes licensed projects:food production;food sales;Health food production;Food additive production;Power generation business,Transmission business,for(match)Electric business;Production of edible fungi;Edible fungi management;soy products manufacturing;beverage production;Grain Processed Food Production;Inspection and testing service;Crop Seed Management;dairy production;Cosmetic production;feed production;road freight transport(Does not contain dangerous goods);Biomass gas production and supply.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:food sales(Only sell prepackaged food);Food Internet Sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Edible mushroom cultivation;Primary processing of edible agricultural products;Wholesale of edible agricultural products;vegetable planting;Wholesale Fresh Vegetables;Crop Seed Management(Packaged seeds no longer in packs only);packaging service;fertilizer sales;raw nuts,dried fruit sales;Clothing and apparel wholesale;Wholesale shoes and hats;needle textile sales;cotton,hemp sales;pulp sales;wood sales;Rubber Products Sales;Bio-organic fertilizer research and development;Sales of agricultural and sideline products;Metal Ore Sales;Special Equipment Repair;Wholesale of hardware products;Metal Products Sales;Sales of plastic products;Sales of building materials;Broadcasting, film and television equipment sales;Communication equipment sales;electronics sales;Machinery sales;Auto Parts Wholesale;Gold and Silver Products Sales;Cosmetics Retail;General merchandise sales;Home Appliance Sales;Jewelry Manufacturing;Jewelry Retail;Wholesale Jewelry;Animal Husbandry and Fishery Feed Sales;General Cargo Warehousing Services(Does not contain hazardous chemicals and other items that require approval);Low temperature storage(Does not contain hazardous chemicals and other items that require approval);Domestic trade agent;Import and export;Technology Import and Export;Import and export agency.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shuguang Hospital is a private company headquartered in Shanghai, China, that operates as a hospital.

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and MedTech. The Consumer Health segment includes products focused on personal healthcare used in the Skin Health/Beauty, Over-the-Counter medicines, Baby Care, Oral Care, Women’s Health and Wound Care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular and metabolic diseases. The MedTech segment offers products used in the interventional solutions. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.

Huai'an Anlai Biotechnology Co., Ltd., established on 2018-07-11, Business scope includes biotechnology,medical technology,Genetic Testing Items(Does not include medical activities)research and development,technology transfer,technical consulting,Technical Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Prison (Shandong) Biomedical Technology Co., Ltd., established on 2020-07-30, Business scope includes general items:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Chemical product sales(No licensed chemical products)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)licensed items:Import and export;Technology Import and Export;Import and export agency(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results)

Shandong Discovery Biotechnology Co., Ltd., established on 2018-02-07, Business scope includes biotechnology,medicine,Healthy food,Health Supplies,Technology research and development of instruments and meters,technical consulting,technology transfer,Technical Services;bio-pharmacy;medical instruments,Disinfectant,Research and development of cell products,Sales,Application and promotion;Genetic Testing Technology Services,technical consulting;medical service;Import and export;Technology Import and Export;cell engineering,cell expansion,stem cell,Technology development of immune cells,technology transfer,Technical Advisory Services;Biotechnology R&D,to promote;Kit development;International Trade Agency Service;food development,Sales;Tissue cell bank construction,operate,maintain;chemical agent(Free of dangerous chemicals and precursor drugs),Biological product,cosmetic,medicine,Sales of laboratory equipment and consumables;Conference and Exhibition Services;Health Advisory;health management;Health Technology Project Development;Health record management;Health Information Consultation;Medical device production and other legal,regulations,Items that are not prohibited by the State Council's decision and do not require a business license.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Tianjin Mediruikang Biomedical Technology Co., Ltd., established on 2010-12-06, Business scope includes biomedical technology development,transfer,consultation service,Chemical raw materials,Wholesale and retail of instruments and meters,Import and export of goods or technology(Except for the import and export of goods and technologies that are prohibited by the state or involve administrative approval).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)